The New England Journal Of Medicine Publishes Clinical Results On Karo Bio's
Source: Medical News Today
Friday 12th March, 2010
The Swedish biotech company Karo Bio (Reuters: KARO.ST) announced the publication of results from a clinical phase II trial evaluating the company's liver selective thyroid hormone receptor agonist ep... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story
